Protecting the Heart During Breast Cancer Radiation

For patients with breast cancer, the journey toward survivorship often involves a delicate balancing act: delivering powerful, curative radiation while shielding vital organs like the heart and lungs from long-term damage. As treatment technology advances, the conversation has shifted from simply "curing" to "curing with minimal late-term toxicity."

CURE sat down with Dr. Wendy Woodward, a radiation oncologist at The University of Texas MD Anderson Cancer Center, to discuss the evolution of heart-sparing techniques. By simply changing how a patient breathes, clinicians can physically move the heart away from the radiation beam, drastically reducing the dose to cardiac tissue.

Woodward also addressed the growing friction between clinical innovation and the insurance landscape. New billing codes and coverage pushbacks are complicating access to these standard-of-care techniques, particularly for right-sided treatments where the benefit, though present, is often scrutinized by payers.

Beyond current standards, Woodward delved into the "pushing the envelope" era of radiation, proton therapy. With a clinical trial currently evaluating whether protons offer a superior cardiac safety profile over traditional photons, Woodward provided a perspective on the future of the field.

Patients often worry about the long-term effects of radiation on the heart and the lungs. Can you speak to the latest heart-sparing techniques and how you decide which patients need such high-tech interventions?

One of the most standard things that we do to reduce dose to the heart is treat patients while they hold their breath. When you hold your breath, the diaphragm pulls down on the heart, and it goes from being fat and round to long and skinny, and it moves away from the chest wall. And many studies, including our own, have demonstrated that you can reduce the dose to the heart by doing that.

A real challenge that we're facing right now is that the billing codes for breast radiation therapy and radiation therapy in general changed in January, and now that takes into account as a billing focus whether or not you're doing breath hold. And I think we're all experiencing this pushback from the insurance companies that they don't want to be doing breath hold for right-sided breast cancer. They don't want to be doing breath hold for the last week of treatment if they feel that it could be done differently.

These aren't issues that should be determined by the insurance companies. It's a little bit of a new space and a frustrating space, because that's a really impressive way to reduce heart dose and reduce people's risk of future heart disease.

There is a randomized study that asked whether or not protons add a benefit for cardiac outcome in patients who need more advanced radiation, including treating the regional nodes, and it'll still be a few years before the outcome of that trial is published, but I think that'll be a really bellwether study as to whether or not what we're doing in contemporary radiation therapy across the country that's available to everyone is good enough, or if you can make it better with protons — do we need to really be pushing that envelope?

Transcript has been edited for clarity and conciseness.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.